ASX
NeuroScientific Biopharmaceuticals Ltd
NSB:ASX•Healthcare
Sensitive ASX Announcement
HREC decision to not approve Phase I Clinical Trial
Published: 07/09/22, 08:12am (AEST)•1 pages